7Baggers
 ALGS Financials: Revenue Breakdown, Margins & Competitor Comparison  Intellectia AI Fri, 10 Jul 2026 00:46:34 GMT
 H.C. Wainwright reiterates Aligos Therapeutics stock rating at buy  Investing.com Wed, 08 Jul 2026 12:03:38 GMT
 symbol__ stock quote price and forecast  CNN Tue, 07 Jul 2026 10:34:14 GMT
 Aligos Therapeutics Secures $25M Upfront Payment in Licensing De  GuruFocus Tue, 07 Jul 2026 06:56:15 GMT
 why is aligos therapeutics stock surging today? by investing.com  Investing.com Nigeria Mon, 06 Jul 2026 21:37:36 GMT
 Why is Aligos Therapeutics stock surging today?  Investing.com Mon, 06 Jul 2026 21:03:40 GMT
 Aligos receives $25M upfront payment from China licensing deal  Investing.com Mon, 06 Jul 2026 20:44:34 GMT
 Aligos Therapeutics stock jumps on $25M China licensing deal  Investing.com Mon, 06 Jul 2026 20:09:39 GMT
 algs news | aligos therapeutics inc (nasdaq:algs)  ChartMill Fri, 03 Jul 2026 00:17:24 GMT
 discipline and rules-based execution in algs response  Stock Traders Daily Thu, 02 Jul 2026 01:20:02 GMT
 Form 4 Aligos Therapeutics Inc For: 29 June By Investing.com  Investing.com Canada Mon, 29 Jun 2026 20:48:49 GMT
 Director at Aligos (ALGS) granted option on 5,860 common shares  Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
 Aligos Therapeutics, Inc. Actuals & Estimates (NASDAQ:ALGS)  TradingView Mon, 29 Jun 2026 05:57:48 GMT
 Aligos Therapeutics, Inc.(NasdaqCM: ALGS) added to Russell Microcap Index  marketscreener.com Mon, 29 Jun 2026 05:37:51 GMT
 ALGS Forecast — Price Target — Prediction for 2027  TradingView Fri, 26 Jun 2026 08:55:39 GMT
 5wk0 forecast — price target — prediction for 2027  TradingView Fri, 26 Jun 2026 06:56:19 GMT
 aligos therapeutics, inc. actuals & estimates (dus:5wk0)  TradingView Fri, 26 Jun 2026 05:56:57 GMT
 aligos therapeutics, inc. actuals & estimates (dus:5wk0)  TradingView Thu, 25 Jun 2026 22:06:36 GMT
 price to sales forward of aligos therapeutics, inc. – nasdaq:algs  TradingView Thu, 25 Jun 2026 09:39:37 GMT
 aligos therapeutics inc (algs) institutional confidence  TradingKey Tue, 23 Jun 2026 07:00:00 GMT
 Behavioral Patterns of ALGS and Institutional Flows  Stock Traders Daily Sun, 21 Jun 2026 00:08:02 GMT
 aligos therapeutics inc (algs) institutional confidence  TradingKey Thu, 18 Jun 2026 09:26:46 GMT
 Aligos Therapeutics (ALGS) Gets a Buy from Cantor Fitzgerald  The Globe and Mail Sat, 30 May 2026 07:00:00 GMT
 how (algs) movements inform risk allocation models  Stock Traders Daily Fri, 29 May 2026 21:30:02 GMT
 aligos’ alg-215007 candidate aso for hdv infection  BioWorld News Fri, 29 May 2026 13:00:00 GMT
 cantor fitzgerald reiterates aligos stock overweight on hbv data  Investing.com Fri, 29 May 2026 07:00:00 GMT
 Aligos Therapeutics Presents Positive Data at the EASL Congress 2026  Investing News Network Thu, 28 May 2026 07:00:00 GMT
 Pevifoscorvir Shows Strong HBV Activity, Durable Antigen Suppression  Journal of Managed Care Thu, 28 May 2026 07:00:00 GMT
 aligos therapeutics initiated with a buy at lake street  TipRanks Thu, 28 May 2026 07:00:00 GMT
 aligos therapeutics presents data at easl congress  TipRanks Wed, 27 May 2026 17:57:31 GMT
 aligos therapeutics (algs) showcases promising data at easl cong  GuruFocus Wed, 27 May 2026 12:33:45 GMT
 aligos therapeutics presents positive data at the easl congress 2026  Investing News Network Wed, 27 May 2026 07:30:00 GMT
 algs - aligos therapeutics inc stock price and quote  Finviz Tue, 26 May 2026 15:50:04 GMT
 algs initiated coverage by cantor fitzgerald -- rating set to ov  GuruFocus Thu, 21 May 2026 18:42:20 GMT
 algs news | aligos therapeutics inc (nasdaq:algs)  ChartMill Wed, 20 May 2026 07:00:00 GMT
 liver disease drug data: aligos secures 10 easl 2026 slots  Stock Titan Wed, 13 May 2026 06:07:01 GMT
 liver disease drug data: aligos secures 10 easl 2026 slots  Stock Titan Tue, 12 May 2026 07:00:00 GMT
 tradingkey  TradingKey Mon, 11 May 2026 13:34:35 GMT
 algs: aligos therapeutics - interactive chart  Zacks Investment Research Mon, 11 May 2026 12:42:53 GMT
 aligos lands fda fast track and a $25m china deal for hbv drug  Stock Titan Thu, 07 May 2026 07:00:00 GMT
 how aligos therapeutics inc. (algs) affects rotational strategy timing  Stock Traders Daily Thu, 07 May 2026 07:00:00 GMT
 aligos therapeutics to announce 1st quarter 2026 financial results on may 7, 2026  Investing News Network Thu, 07 May 2026 07:00:00 GMT
 hepatitis b virus (hbv) capsid inhibitors market analysis:  openPR.com Fri, 01 May 2026 07:00:00 GMT
 [ars] aligos therapeutics, inc. sec filing  Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
 aligos and xiamen amoytop sign deal for hbv therapy  MSN Wed, 29 Apr 2026 03:36:58 GMT
 aligos and xiamen amoytop sign deal for hbv therapy  MSN Tue, 28 Apr 2026 12:00:19 GMT
 aligos and xiamen amoytop sign deal for hbv therapy  MSN Mon, 27 Apr 2026 02:14:53 GMT
 (algs) and the role of price-sensitive allocations  Stock Traders Daily Sun, 26 Apr 2026 07:00:00 GMT
 aligos and xiamen amoytop sign deal for hbv therapy  MSN Sun, 26 Apr 2026 02:15:08 GMT
 aligos and xiamen amoytop sign deal for hbv therapy  MSN Sat, 25 Apr 2026 17:52:35 GMT
 aligos therapeutics (algs) gets a buy from h.c. wainwright  The Globe and Mail Fri, 24 Apr 2026 07:00:00 GMT
 aligos therapeutics jumps on china licensing agreement  MSN Fri, 24 Apr 2026 02:57:14 GMT
 aligos and xiamen amoytop sign deal for hbv therapy  MSN Thu, 23 Apr 2026 23:17:27 GMT
 deal watch: first quarter posted high volume, dollar value in alliance deals  Citeline News & Insights Thu, 23 Apr 2026 07:00:00 GMT
 aligos therapeutics jumps on china licensing agreement  MSN Thu, 23 Apr 2026 04:45:10 GMT
 aligos and xiamen amoytop sign deal for hbv therapy  MSN Wed, 22 Apr 2026 05:04:19 GMT
 grce stock price and chart — nasdaq:grce  TradingView Tue, 21 Apr 2026 07:00:00 GMT

Aligos Therapeutics, Inc
(NASDAQ:ALGS) 

ALGS stock logo

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a synthetic oligonucleotide that is in Phase I clinical trial for the treatment of chronic h...

Founded: 2018
Full Time Employees: 73
CEO: Lawrence M. Blatt  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends